IP Library › Assignment 031416/0863
Patent Assignment
Reel/Frame 031416/0863

Change of Name

Recorded: 2013-10-16 Pages: 12
Assignor
WATSON PHARMACEUTICALS, INC.
Executed: 2013-01-17
Assignee
ACTAVIS, INC.
400 INTERPACE PARKWAY, MORRIS CORPORATE CENTER III, PARSIPPANY, NEW JERSEY, 07054
Covered Property (1)
Novel Pharmaceutical Formulation Containing a Biguanide and a Thiazolidinedione Derivative
Patent: 8,668,931 →
Application: 13/889,441 →
Publication: US 2013/0266647
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 20, 2017
From: ALLERGAN FINANCE, LLC
To: ACTAVIS HOLDCO US, INC.
Reel/Frame 041449/0799 →
Change of Name Jan 20, 2017
From: ACTAVIS, INC.
To: ALLERGAN FINANCE, LLC
Reel/Frame 041459/0788 →